Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body result in autoimmune diseases. These diseases are characterized by chronic inflammatory processes that activate the innate immune system and the production of antibodies that destroy host tissues. These inflammatory processes can be caused by genetic or environmental factors or infections.

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

Autoimmune diseases

PART 05: Market landscape

Market overview

Five forces analysis

PART 06: Market segmentation by disease type

Systemic autoimmune disease diagnostics

Global systemic autoimmune disease market overview

Localized autoimmune disease diagnostics

Global localized autoimmune disease diagnostics market

overview

PART 07: Market segmentation by product type

Analyzers

Global autoimmune diseases analyzers market

overview

Assay kits

Global autoimmune disease assay kits market

overview

PART 08: Market segmentation by test type

ANA tests

CRP

Urinalysis test

ESR

CMP test

Other

PART 09: Market segmentation by end-user

Hospitals

Diagnostic and research laboratories

PART 10: Geographical segmentation

Autoimmune disease diagnostics market in Americas

Autoimmune disease diagnostics market in EMEA

Autoimmune disease diagnostics market in APAC

PART 11: Market drivers

Discovery of novel biomarkers leading to improved

autoimmune diagnosis

Advancements in laboratory automation platforms

Increasing M&A

Product approvals and launches

PART 12: Impact of drivers

PART 13: Market challenges

Limitation of autoimmune disease diagnostics

Significant concerns over standardization and quality of

immunoassay kits

Lack of understanding on the basic etiology of several

autoimmune diseases

Shortage of skilled technicians for performing diagnostic

assays

PART 14: Impact of drivers and challenges

PART 15: Market trends

Focus on companion diagnostic tests

Shift from monoplex to multiplex testing

Collaboration between pharma and diagnostic

companies

Growing consumer shift toward direct-to-consumer

testing

PART 16: Vendor landscape

Competitive scenario

Key news

Vendors market share 2015

PART 17: Key vendor analysis

Abbott Laboratories

Beckman Coulter

Bio-Rad Laboratories

EUROIMMUN

Inova Diagnostics

Roche Diagnostics

Siemens Healthcare

Other prominent vendors

PART 18: Appendix

List of abbreviations

PART 19: Explore Technavio